Lipo-C Injection vs Tesofensine
A side-by-side research comparison of Lipo-C Injection and Tesofensine across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Lipo-C Injection | Tesofensine |
|---|---|---|
| Full name | Lipotropic MIC + B12 Injection | Tesofensine (Triple Monoamine Reuptake Inhibitor) |
| Category | Weight Management | Weight Management |
| Status | Compounded medication | Phase 3 Clinical Trial |
| Mechanism | Methionine provides sulfur for detoxification, inositol supports fat transport from liver, choline emulsifies cholesterol and fat, B12 boosts cellular energy metabolism and red blood cell production. | Blocks presynaptic reuptake of noradrenaline, dopamine, and serotonin in the hypothalamus, enhancing satiety signaling, reducing food reward, and increasing thermogenesis. |
| Molecular weight | Combination compound | 329.4 Da |
| Half-life | Variable by component | 8-10 days |
| Bioavailability | ~100% IM injection | High (oral ~93%) |
| Typical dose | 1 mL | 0.25-0.5 mg |
| Frequency | 1-2x per week | Once daily |
| Route | Intramuscular or subcutaneous injection | Oral |
Lipo-C Injection reported benefits
- Enhanced fat metabolism
- Liver support
- Increased energy
- B12 optimization
- Complements weight loss protocols
Tesofensine reported benefits
- Significant appetite reduction
- Increased metabolic rate
- Improved satiety signaling
- 10-12% body weight loss
- Oral administration convenience
Related comparisons
Research and educational reference only. Not medical advice.